Sera Prognostics/$SERA
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Sera Prognostics
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
- Ticker
- $SERA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 72
- Headquarters
- Salt Lake City, United States
- Website
- www.sera.com
Sera Prognostics Metrics
BasicAdvanced
$77M
-
-$0.67
-
-
Price and volume
Market cap
$77M
52-week high
$3.85
52-week low
$1.56
Average daily volume
31K
Financial strength
Current ratio
1.884
Quick ratio
1.798
Long term debt to equity
0.058
Total debt to equity
0.058
Interest coverage (TTM)
-6,200.83%
Profitability
EBITDA (TTM)
-36.501
Gross margin (TTM)
-103.13%
Net profit margin (TTM)
-34,866.67%
Operating margin (TTM)
-38,755.21%
Management effectiveness
Return on assets (TTM)
-24.72%
Return on equity (TTM)
-49.73%
Valuation
Price to revenue (TTM)
1,018.373
Price to book
1.47
Price to tangible book (TTM)
1.49
Price to free cash flow (TTM)
-3.367
Free cash flow yield (TTM)
-29.70%
Free cash flow per share (TTM)
-0.576
Growth
Revenue change (TTM)
1.05%
Earnings per share change (TTM)
-10.31%
3-year revenue growth (CAGR)
-33.74%
3-year earnings per share growth (CAGR)
-18.18%
Sera Prognostics Financial Performance
Revenues and expenses
Sera Prognostics Earnings Performance
Company profitability
Upcoming events
No upcoming events
Sera Prognostics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.